SuanFarma-Header SuanFarma-Header

X

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Loading...

    All Data

    Filters Filter
    ×
    FILTER:
    filter News Type
      filter Company
        filter Product Type
          filter Deal Size
            filter Upfront Payment

              Active Filter(s):

              refreshReset Filter
              refresh Reset Filter
              price-trend All Drugs in Dev.

              Product Type

              Companies

              Lonza Group

              • Deals

              Virtual BoothGlobal Pharmaceutical Dosage Solutions Company

              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth

              Mediterranean Congress of Chemical

              Participation Not Confirmed

              Update your events

              aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibod...

              Lead Product(s): ATYR2810

              Therapeutic Area: Oncology Product Name: ATYR2810

              Highest Development Status: IND Enabling Product Type: Large molecule

              Partner/Sponsor/Collaborator: aTyr Pharma

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership April 14, 2021

              Details:

              Under the terms of the agreement, Lonza will utilize its Ibex® Design, a fully integrated end-to-end program, to manufacture cGMP material for ATYR2810.

              Lonza Group

              • Deals

              Virtual BoothGlobal Pharmaceutical Dosage Solutions Company

              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth

              Mediterranean Congress of Chemical

              Participation Not Confirmed

              Update your events

              Triumvira Immunologics and Lonza Announce Collaboration to Develop Innovative Point-o...

              Lead Product(s): TAC01-HER2

              Therapeutic Area: Oncology Product Name: Undisclosed

              Highest Development Status: IND Enabling Product Type: Cell and Gene therapy

              Partner/Sponsor/Collaborator: Triumv